Company intelligence / Profile preview

CSC Pharmaceuticals International

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

CSC Pharmaceuticals is a licensed distributor and trader of pharmaceutical products, focusing on life-saving medications, antibacterial products, and biopharmaceuticals. They source products from reputed vendors in the US and UK, and distribute them globally after quality testing[1][4].

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: Small moleculesBiopharmaceuticals
Industry: Biotech

Drug pipeline

3 assets

ponatinib

Commercial

Indications: Chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia

2 more assets in the full pipeline.

Request access →

Partnerships

Partnerships with multinational companies based in India[4]

Beyond the preview

Go deeper on CSC Pharmaceuticals International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CSC Pharmaceuticals International.

Explore the full profile